(85 days)
No
The document describes a dental bonding agent and its performance characteristics, with no mention of AI or ML technology.
No.
The device is a dental bonding agent used to improve retention of restorative materials and seal cavities, not to treat disease or symptoms.
No
Explanation: The device is a resin tooth bonding agent used for dental restorations and other treatments, not for diagnosing medical conditions. Its intended uses are primarily therapeutic and restorative in nature, such as bonding materials, sealing cavities, and treating hypersensitive surfaces.
No
The device description explicitly states it is composed of materials like dimethacrylate monomers and includes physical components (primer, bond, accessories), indicating it is a physical dental bonding agent, not software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended uses listed are all related to dental procedures performed directly on the patient's tooth (direct restorations, cavity sealing, treating hypersensitivity, repairs, surface treatment, core build-ups, sealing under amalgam). These are clinical applications, not laboratory tests performed on samples taken from the body.
- Device Description: The device is classified as a "resin tooth bonding agent" and is described as being "painted on the interior of a prepared cavity of a tooth." This further reinforces its use in a clinical dental setting.
- Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
- Analyzing samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in samples
- Providing information for diagnosis, monitoring, or screening based on laboratory results.
Therefore, based on the information provided, CLEARFIL SE BOND PLUS is a dental device used for bonding and sealing in the mouth, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
CLEARFIL SE BOND PLUS is indicated for the following applications:
- Direct restorations using light-cured composite resin or compomer
- Cavity sealing as a pretreatment for indirect restorations
- Treatment of hypersensitive and/or exposed root surfaces
- Intraoral repairs of fractured crowns/bridges made of porcelain, hybrid ceramics or composite resin using light cured composite resin
- Surface treatment of prosthetic appliances made of porcelain, hybrid ceramics and cured composite resin
- Core build-ups using light- or dual-cured composite resin
- Cavity sealing under amalgam restorations
Product codes (comma separated list FDA assigned to the subject device)
KLE
Device Description
CLEARFIL SE BOND PLUS is classified into the resin tooth bonding agent, CFR 21 Section 872.3200, because it is a device composed of materials such as dimethacrylate monomers intended to painted on the interior of a prepared cavity of a tooth to improve retention of restorative materials.
This device consists of the primer, the bond and the accessories, and is substantially equivalent in design to CLEARFIL SE BOND.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Tooth / Oral Cavity
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The biocompatibilities of the new ingredient, MDPB, and this device were evaluated according to ISO 7405: 1997 and ISO 10993-1: 1997. As to the results, this device is judged that it is substantially equivalent in safety to the legally marketed predicate devices.
The bond strengths between bovine tooth and a composite resin and a fresh amalgam were evaluated in comparison with the legally marketed predicate devices; CLEARFIL SE BOND etc. The bond strengths between composite resin and various substances were evaluated when used as intra oral repairs of fractured crowns/bridges. The marginal sealing was also evaluated when used as direct filling and cavity sealing under amalgam restoration. As to the result, this device is substantially equivalent to the legally marketed predicate devices in effectiveness.
The amount of fluorine ion from the cured material immersed in water was evaluated in comparison with the legally marketed predicate devices; TOKUYAMA ONE UP-BOND F IMPERVA FLUORO BOND and PANAVIA F. The changes in mechanical strength due to fluorine releasing were also evaluated. As to the result, this device is substantially equivalent in the fluoride releasing property including the change of mechanical strength to the legally marketed predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K012442, K012440, K993917, K953612, K982394, K014027
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K012441, K021805, K855211, K012707
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3200 Resin tooth bonding agent.
(a)
Identification. A resin tooth bonding agent is a device material, such as methylmethacrylate, intended to be painted on the interior of a prepared cavity of a tooth to improve retention of a restoration, such as a filling.(b)
Classification. Class II.
0
Image /page/0/Picture/2 description: The image is a black and white logo for Kuraray. The logo features a stylized letter "K" design. The word "KURARAY" is printed in a bold, sans-serif font below the symbol.
].
KURARAY MEDICAL INC.
Dental Material Department 3-1-6 Nihonbashi, Chuo-ku, Tokyo 103-8254, Japan Tel : +81.3.3277.6949 Fax : +81.3.3277.6956
510(k) SUMMARY
| Submitter | |
|---|---|
| 1) Name | KURARAY MEDICAL INC. |
| 2) Address | 1621 Sakazu, Kurashiki, Okayama 710-8622, Japan |
| 3) Contact person | Koji Nishida |
| Dental Material Department | |
| 4) Date | November 11, 2002 |
| 5) Contact person in U.S.A. | Masaya Sasaki |
| Kuraray America, Inc. | |
| 101 East 52nd Street, 26th Floor, New York, NY 10022 | |
| Telephone: (212)-986-2230 (Ext.115) | |
| Facsimile: (212)-867-3543 |
: !. Name of Device
| 1) Proprietary Name | CLEARFIL SE BOND PLUS |
|---|---|
| 2) Classification Name | Resin tooth bonding agent (21CFR 872.3200) |
| 3) Common/Usual Name | Resin-based dental adhesive system |
-
:). Predicate device:
The predicate products are; -
a) Resin Tooth Bonding Agent
| 1. | CLEARFIL SE BOND | by Kuraray Medical Inc. | (K012442) |
|---|---|---|---|
| 2. | CLEARFIL LINER BOND 2V | by Kuraray Medical Inc. | (K012440) |
| 3. | TOKUYAMA ONE-UP-BOND F | by Tokuyama America Inc. | (K993917) |
| 4. | IMPERVA FLUORO BOND | by Shofu Dental Corp. | (K953612) |
| 5. | PRIME & BOND NT DUAL CURE | ||
| UNIVERSAL DENTAL ADHESIVE SYSTEM | by Dentsply Intl. | (K982394) | |
| 6. | OPTIBOND SOLO PLUS 4 | by KERR DENTAL | |
| MATERIALS CENTER. | (K014027) | ||
| b) | Other dental materials | ||
| 1. | PANAVIA F | by Kuraray Medical Inc. | (K012441) |
| 2. | SEAL & PROTECT PROTECTIVE SEALANT | by Dentsply Intl. | (K021805) |
| 3. | PANAVIA EX | by Kuraray Co., Ltd. | (K855211) |
-
- ESTENIA
(K012707) by Kuraray Medical Inc.
- ESTENIA
-
- Description for the premarket notification
CLEARFIL SE BOND PLUS is classified into the resin tooth bonding agent, CFR 21 Section 872.3200, because it is a device composed of materials such as dimethacrylate monomers intended to painted on the interior of a prepared cavity of a tooth to improve retention of restorative materials.
- Description for the premarket notification
1
5 Staterient of the intended use
This device has the following indications for use which are substantially equivalent to the legally marketed predicate devices.
| Indications for use | Predicate device |
|---|---|
| 1) Direct restorations using light-cured composite resin or | |
| compomer | CLEARFIL SE BOND |
| (K012442) | |
| 2) Cavity sealing as a pretreatment for indirect restorations | |
| 3) Treatment of hypersensitive and/or exposed root surfaces | |
| 4) Intraoral repairs of fractured crowns/bridges made of | |
| porcelain, hybrid ceramics or composite resin using | |
| light-cured composite resin | |
| 5) Surface treatment of prosthetic appliances made of | |
| porcelain, hybrid ceramics and cured composite resin | |
| 6) Core build-ups using light- or dual-cured composite resin | OPTIBOND SOLO PLUS 4 |
| (K014027) | |
| 7) Cavity sealing under amalgam restorations | PRIME & BOND NT DUAL |
| CURE UNIVERSAL DENTAL | |
| ADHESIVE SYSTEM | |
| (K982394) |
3. Statement of the technological characteristics and safety
3-1 Design/Components
This device consists of the primer, the bond and the accessories, and is substantially equivalent in design to CLEARFIL SE BOND.
6-2 Material and chemical ingredients
The ingredients other than MDPB are used in the legally marketed predicate devices, C. EARFIL SE BOND etc. The biocompatibilities of the new ingredient, MDPB, and this device were evaluated according to ISO 7405: 1997 and ISO 10993-1: 1997. As to the results, this device is judged that it is substantially equivalent in safety to the legally marketed predicate devices.
6-3 Mechanical properties
The bond strengths between bovine tooth and a composite resin and a fresh amalgam were evaluated in comparison with the legally marketed predicate devices; CLEARFIL SE BOND etc. The bond strengths between composite resin and various substances were evaluated when used as intra oral repairs of fractured crowns/bridges. The marginal sealing was also evaluated when used as direct filling and cavity sealing under amalgam restoration. As to the result, this device is substantially equivalent to the legally marketed predicate devices in effectiveness.
6-4 Physical properties
The amount of fluorine ion from the cured material immersed in water was evaluated in comparison with the legally marketed predicate devices; TOKUYAMA ONE UP-BOND F IMPERVA FLUORO BOND and PANAVIA F. The changes in mechanical strength due to fluorine releasing were also evaluated. As to the result, this device is substantially equivalent in the fluoride releasing property including the change of mechanical strength to the legally
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle with three lines representing its head and wings. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around the perimeter of the circle.
FEB 11 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Kuraray Medical, Incorporated C/O Ms. Masaya Sasaki Kuraray America, Incorporated 101 East 52nd Street, 26th Floor New York, New York 10022
Re: K023842
Trade/Device Name: CLEARFIL SE BOND PLUS Regulation Number: 872.3200 Regulation Name: Resin Tooth Bonding Agent Regulatory Class: II Product Code: KLE Dated: November 12, 2002 Received: November 18, 2002
Dear Ms. Sasaki:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If vour device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Sasaki
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Penner
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
4
[CLEARFIL SE BOND PLUS, Kuraray Medical Inc.]
3842 162
Indications for Use
('LEAFIL SE BOND PLUS is indicated for the following applications'
-
- :Direct restorations using light-cured composite resin or compomer
-
- Cavity sealing as a pretreatment for indirect restorations
-
- 'Treatment of hypersensitive and/or exposed root surfaces
-
- Intraoral repairs of fractured crowns/bridges made of porcelain, hybrid ceramics or composite resin using light cured composite resin
-
- Surface treatment of prosthetic appliances made of porcelain, hybrid ceramics and cured composite resin
-
- Core build-ups using light- or dual-cured composite resin
-
- Cavity sealing under amalgam restorations
"PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Part: 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
Kein Mulay for MSR
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: